High density lipoprotein measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Exome-wide association study of plasma lipids in >300,000 individuals.
|
29083408 |
2017 |
Colorectal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
What's more, the expression levels of TMED6-COG8 chimera in esophagus cancers (n=32), gastric cancers (n=11), colorectal cancers (n=12), hepatocellular carcinomas (n=10) and non-small-cell lung cancers (n=12) were assessed.
|
26045774 |
2015 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
What's more, the expression levels of TMED6-COG8 chimera in esophagus cancers (n=32), gastric cancers (n=11), colorectal cancers (n=12), hepatocellular carcinomas (n=10) and non-small-cell lung cancers (n=12) were assessed.
|
26045774 |
2015 |
Alveolar Soft Part Sarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Then, we also examined the expression level of TMED6-COG8 chimera in Xp11.2 translocation alveolar soft part sarcoma.
|
26045774 |
2015 |
Malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
What's more, the expression levels of TMED6-COG8 chimera in esophagus cancers (n=32), gastric cancers (n=11), colorectal cancers (n=12), hepatocellular carcinomas (n=10) and non-small-cell lung cancers (n=12) were assessed.
|
26045774 |
2015 |
Adult Alveolar Soft Part Sarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Then, we also examined the expression level of TMED6-COG8 chimera in Xp11.2 translocation alveolar soft part sarcoma.
|
26045774 |
2015 |
Childhood Alveolar Soft Part Sarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Then, we also examined the expression level of TMED6-COG8 chimera in Xp11.2 translocation alveolar soft part sarcoma.
|
26045774 |
2015 |
Malignant neoplasm of esophagus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
What's more, the expression levels of TMED6-COG8 chimera in esophagus cancers (n=32), gastric cancers (n=11), colorectal cancers (n=12), hepatocellular carcinomas (n=10) and non-small-cell lung cancers (n=12) were assessed.
|
26045774 |
2015 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
What's more, the expression levels of TMED6-COG8 chimera in esophagus cancers (n=32), gastric cancers (n=11), colorectal cancers (n=12), hepatocellular carcinomas (n=10) and non-small-cell lung cancers (n=12) were assessed.
|
26045774 |
2015 |
Clear-cell metastatic renal cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Owing to recent advances in microarray and RNA-Seq, Pflueger et al. have discovered that TMED6-COG8 is dramatically increased in TFE3 translocation RCCs, compared with clear cell RCCs and papillary RCCs, implying that TMED6-COG8 might be a new molecular tumor marker of TFE3 translocation RCCs.
|
26045774 |
2015 |
MiT family translocation renal cell carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
|
26045774 |
2015 |